Exchange: NASDAQ·Updated 07:30 PM EDT

LGND News

News
all
press releases
If You Invested $100 In Ligand Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today
Ligand Pharmaceuticals (NASDAQ:LGND) has outperformed the market over the past 5 years by 17.28% on an annualized basis producing an average annual return of 28.4%. Currently, Ligand Pharmaceuticals has a marketread more...
Benzinga
More News
$100 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Ligand Pharmaceuticals (NASDAQ:LGND) has outperformed the market over the past 15 years by 14.91% on an annualized basis producing an average annual return of 28.27%. Currently, Ligand Pharmaceuticals has a marketread more...
Benzinga
Ligand Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Ligand Pharmaceuticals Inc (Symbol: LGND) have crossed above the average analyst 12-month target price of $301.78, changing hands for $303.39/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down...
Nasdaq News: Markets
Ligand Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Ligand Pharmaceuticals Inc (Symbol: LGND) have crossed above the average analyst 12-month target price of $271.00, changing hands for $274.88/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down...
Nasdaq News: Markets
Ligand Pharmaceuticals Director Unloads 2,501 Shares Should You Be Concerned?
Key PointsKozarich sold 2,501 common shares...
Nasdaq News: Markets
A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million
Key Points5,000 shares were sold for a total transaction value of ~$1.14 million on June 1, 2026, at a weighted average price around $227.06 per share...
Nasdaq News: Markets
Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Insider Sells 5,000 Shares of Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) insider Andrew Reardon sold 5,000 shares of the business's stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $231.31, for a total transaction of $1,156,550.00. Following the completion of the...
MarketBeat
Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Kornitzer Capital Management Inc. KS
Kornitzer Capital Management Inc. KS lessened its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 33.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,342 shares of the biotechnology compan...
MarketBeat
HC Wainwright Brokers Increase Earnings Estimates for LGND
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) - Stock analysts at HC Wainwright lifted their Q3 2026 earnings per share estimates for Ligand Pharmaceuticals in a research note...
MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of "Moderate Buy" from Analysts
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) has earned an average rating of "Moderate Buy" from the eight brokerages that are currently covering the company, Marketbeat...
MarketBeat

Advertisement|Remove ads.